MIST
Milestone Pharmaceuticals Inc.
$1.40
-$0.01(-0.71%)
25
Overall
--
Value
27
Tech
23
Quality
Market Cap
$178.03M
Volume
1.27M
52W Range
$1.00 - $3.06
Target Price
$6.33
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | -- | -- | -- | $5.0M | $1.0M | -- | -- | ||
| Total Revenue | -- | -- | -- | $5.0M | $1.0M | -- | -- | ||
| GROSS PROFIT | |||||||||
| Gross Profit | -- | -- | -- | -- | $1.0M | -- | -- | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $40.1M | $38.8M | $44.1M | $64.6M | $47.0M | $31.1M | $35.4M | ||
| Research & Development | $42.0M | $34.5M | $38.7M | $39.8M | $31.1M | $14.4M | $18.1M | ||
| Research Expense | $42.0M | $34.5M | $38.7M | $39.8M | $31.1M | $14.4M | $18.1M | ||
| Selling, General & Administrative | $7.0M | $10.3M | $12.4M | $15.7M | $15.9M | $16.7M | $17.3M | ||
| General & Administrative Expenses | $7.0M | $10.3M | $12.4M | $15.7M | $15.9M | $16.7M | $17.3M | ||
| Salaries & Wages | $-8.9M | $-5.9M | $-7.0M | $-9.1M | $9.5M | -- | -- | ||
| Depreciation & Amortization | -- | -- | -- | $89.0K | $92.0K | $105.0K | -- | ||
| Depreciation & Amortization | -- | -- | -- | $89.0K | $92.0K | -- | -- | ||
| Amortization | -- | $279.0K | $269.0K | $391.0K | $506.0K | $541.0K | -- | ||
| Other Operating Expenses | -- | $318.0K | $314.0K | $490.0K | $681.0K | -- | -- | ||
| OPERATING INCOME | |||||||||
| Operating income | $-40.1M | $-50.7M | $-43.1M | $-59.6M | $-61.1M | $-42.1M | $-62.1M | ||
| EBITDA | $-37.5M | $-50.6M | $-43.0M | $-58.3M | $-57.0M | $-37.4M | $-61.0M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | $2.6M | $3.6M | $3.8M | ||
| Intinc | -- | -- | $220.0K | $1.3M | $4.0M | $4.2M | $2.9M | ||
| Net Non-Operating Interest Income/Expense | -- | -- | $220.0K | $1.3M | $4.0M | $583.0K | $-918.0K | ||
| Gain on Sale of Securities | $2.6M | $726.0K | $220.0K | -- | -- | -- | -- | ||
| Other Income/Expense | $-2.6M | $-726.0K | $-15.0M | $-5.0M | $-1.0M | $8.0K | $-1.5M | ||
| Other Special Charges | -- | -- | $15.0M | $5.0M | $1.0M | -- | $1.5M | ||
| SPECIAL ITEMS | |||||||||
| Special Income Charges | -- | -- | -- | -- | -- | $-1.1M | -- | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-37.5M | $-50.7M | $-43.1M | $-58.4M | $-57.1M | $-37.9M | $-61.6M | ||
| Pre-Tax Income | $-37.5M | $-50.0M | $-28.8M | $-58.4M | $-42.0M | $-30.5M | $-34.8M | ||
| INCOME TAX | |||||||||
| Tax Provision | $-56.0K | $-17.0K | $-1.0K | $251.0K | $205.0K | $21.0K | $-2.3M | ||
| NET INCOME | |||||||||
| Net Income | $-37.4M | $-50.0M | $-42.9M | $-58.4M | $-59.7M | $-41.5M | $-63.1M | ||
| Net Income (Continuing Operations) | $-37.4M | $-50.0M | $-42.9M | $-58.4M | $-59.7M | $-41.5M | $-63.1M | ||
| Net Income (Discontinued Operations) | $-37.4M | $-50.0M | $-42.9M | $-58.4M | $-59.7M | $-41.5M | $-63.1M | ||
| Net Income (Common Stockholders) | $-37.4M | $-50.0M | $-42.9M | $-58.4M | $-59.7M | $-41.5M | $-63.1M | ||
| Normalized Income | -- | -- | $-28.8M | -- | -- | -- | $-37.1M | ||
| TOTALS | |||||||||
| Total Expenses | $40.1M | $38.8M | $44.1M | $64.6M | $47.0M | $31.1M | $35.4M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $15.8M | $29.3M | $28.3M | $42.3M | $42.9M | $62.0M | $84.1M | ||
| Average Shares Outstanding (Diluted) | $15.8M | $29.3M | $28.3M | $42.3M | $42.9M | $62.0M | $84.1M | ||
| Shares Outstanding | $24.6M | $29.8M | $124.5M | $33.3M | $53.1M | $53.4M | $117.7M | ||
| Basic EPS | -- | $-1.7 | $-1.02 | $-1.38 | $-1.39 | $-0.67 | $-0.75 | ||
| Basic EPS (Continuing Operations) | -- | $-1.7 | $-1.02 | $-1.38 | $-1.39 | $-0.67 | $-0.75 | ||
| Diluted EPS | $3.5 | $-1.7 | $-1.02 | $-1.38 | $-1.39 | $-0.67 | $-0.75 | ||
| Diluted EPS (Continuing Operations) | $3.5 | -- | $-1.02 | -- | $-1.39 | $-0.67 | $-0.75 | ||
| OTHER METRICS | |||||||||
| Gain On Sale Of P P E | -- | -- | -- | $348.0K | -- | -- | -- | ||
| Other Gand A | $7.0M | $10.3M | $12.4M | $15.7M | $15.9M | $16.7M | $17.3M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MIST | $1.40 | -0.7% | 1.27M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Milestone Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW